We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
£495.00
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in China
Price data last checked 150 day(s) ago - refreshing...
We'll watch every seller, every day. One email when your price arrives.
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 8 months
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 100 days • 100 data points (No recent data available)
Price Distribution
Price distribution over 100 days • 1 price levels
Price Analysis
Most common price: £495 (100 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 100 days
Product Specifications
- Format
- paperback
- ASIN
- B0BBJWK4JZ
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 16 August 2022
- Listed Since
- 25 August 2022
Similar Products You Might Like
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in Japan
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in India
The 2023-2028 Outlook for Natural Killer Cell Therapeutics for US Zip Codes
The 2023 Report on Natural Killer Cell Therapeutics: World Market Segmentation by City
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
Natural Killer (NK) Cells: Methods and Protocols: 2463 (Methods in Molecular Biology, 2463)
Humana
Natural Killer (NK) Cells: Methods and Protocols: 2463 (Methods in Molecular Biology, 2463)
Humana
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in India
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2016-2021 Outlook for Cancer Therapies in Asia
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in China
The 2023-2028 Outlook for Immunology Therapeutics in China
The 2025-2030 World Outlook for T-Cell Therapies
